Displaying 101–125 of 2607 results for
Can the pharma industry restore luster to its dimming reputation?
Can the industry fix its image problem?
AAM Access! 2019 makes it clear that generics have earned their seat at the table
In 2019, the number of connected OT devices will continue to grow exponentially and so will the OT security threat landscape.
DuPont's novel excipient is designed to better stabilize biologics
OPERATIONS: Leveraging data will not only help pharma predict asset failures, but also eliminate them.
Why manufacturers are seeking alternative options to in-house preparation.
Exploring the benefits of cold-chain-as-a-service
INFORMATICS & DATA MANAGEMENT: How laboratory information management systems are helping pharma stay compliant.
Pharma CMOs are sharpening their arrows and getting noticed
Putman Media's Influential Women in Manufacturing program is now accepting nominations for 2019 honorees
The latest technologies build on past innovations to boost efficiency for manufacturers.
ADC BIO’s innovative technology is helping to usher in oncology’s new age of therapeutic agents
iBio’s unique partnership with Beijing’s CC-Pharming will bring economical, plant-derived rituximab to China
Four contract manufacturers who are redefining what it means to outsource
QUALITY & COMPLIANCE: Why building the right manufacturing partnerships is fundamental to pharma’s journey.
Berkshire Sterile Manufacturing’s souped-up isolator system offers a first-of-its-kind process for sterile manufacturing
China-based Porton Pharma’s partnership with Codexis will bring new and improved manufacturing routes for APIs
If pharma companies truly want to succeed when it comes to drug development, lab automation needs to play a leading role
The importance of laboratory research to the pharmaceutical industry cannot be overstated. The pharma lab makes essential contributions in product/process development and process improvement, setting the stage for successful scale up and commercialization.
Last year, the FDA once again set a new record for new drug approvals and far surpassed its 10-year average.
How AI, data and expertise work together to accelerate insights, develop infrastructure and answer critical scientific questions
In the coming year, several drugs that treat a range of diseases will far surpass the $1 billion blockbuster mark and continue to grow.